Cargando…
TAS-303 effects on urethral sphincter function in women with stress urinary incontinence: phase I study
INTRODUCTION AND HYPOTHESIS: TAS-303, which selectively inhibits noradrenaline reuptake, was developed for treating stress urinary incontinence (SUI). The proximal urethra mainly comprises smooth muscle fibers in which α1 adrenergic receptors are abundant. This study was conducted to evaluate the ef...
Autores principales: | Yono, Makoto, Irie, Shin, Gotoh, Momokazu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7902327/ https://www.ncbi.nlm.nih.gov/pubmed/32747975 http://dx.doi.org/10.1007/s00192-020-04470-7 |
Ejemplares similares
-
Efficacy and safety of the noradrenaline reuptake inhibitor, TAS‐303, in women with stress urinary incontinence: Results of a double‐blind, randomized, placebo‐controlled, early phase II trial
por: Takahashi, Satoru, et al.
Publicado: (2020) -
Prediction of Postradical Prostatectomy Urinary Incontinence Through the Combination of the Urethral Pressure Profile With Electromyography of the Urethral Sphincter
por: Talavera, Jonathan Rodríguez, et al.
Publicado: (2022) -
A novel management for postprostatectomy urinary incontinence: platelet-rich plasma urethral sphincter injection
por: Lee, Ping-Jui, et al.
Publicado: (2021) -
Macroplastique for women with stress urinary incontinence secondary to intrinsic sphincter deficiency
por: Carroll, Timothy F., et al.
Publicado: (2019) -
Clinical significance of anatomical urethral length on stress urinary incontinence women
por: Shin, Yu Seob, et al.
Publicado: (2018)